Canada Pension Plan Investment Board Acquires New Position in Danaher Corporation $DHR

Canada Pension Plan Investment Board bought a new position in Danaher Corporation (NYSE:DHR) in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 2,043,471 shares of the conglomerate’s stock, valued at approximately $389,240,000. Canada Pension Plan Investment Board owned approximately 0.29% of Danaher at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Castlekeep Investment Advisors LLC purchased a new position in Danaher during the second quarter valued at approximately $350,000. Castleark Management LLC bought a new stake in shares of Danaher during the 2nd quarter valued at $994,000. Element Capital Management LLC bought a new stake in shares of Danaher during the 2nd quarter valued at $4,895,000. Osterweis Capital Management Inc. purchased a new position in shares of Danaher during the 2nd quarter valued at $216,000. Finally, Legal & General Group Plc bought a new position in Danaher in the 2nd quarter worth $584,361,000. Institutional investors own 79.05% of the company’s stock.

Danaher Stock Up 0.3%

Shares of DHR stock opened at $215.78 on Wednesday. The stock has a market cap of $151.69 billion, a P/E ratio of 38.33, a PEG ratio of 2.68 and a beta of 0.78. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. The company’s fifty day simple moving average is $197.17 and its two-hundred day simple moving average is $192.36.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The firm had revenue of $6.26 billion during the quarter, compared to analyst estimates of $6.12 billion. During the same quarter last year, the business posted $0.77 earnings per share. The business’s quarterly revenue was up 5.5% compared to the same quarter last year. Analysts predict that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

DHR has been the topic of a number of recent analyst reports. Guggenheim decreased their price target on Danaher from $235.00 to $200.00 and set a “buy” rating on the stock in a report on Wednesday, July 22nd. Weiss Ratings raised Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, July 15th. Stifel Nicolaus cut their target price on Danaher from $260.00 to $220.00 and set a “buy” rating for the company in a research report on Wednesday, July 22nd. Royal Bank Of Canada lifted their target price on Danaher from $200.00 to $215.00 and gave the company an “outperform” rating in a research note on Wednesday, July 22nd. Finally, DZ Bank started coverage on Danaher in a report on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 price target on the stock. One research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $228.91.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.